We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New AI Tool Improves Blood Cancer Diagnosis

By LabMedica International staff writers
Posted on 16 Jun 2025

Traditionally, diagnosing blood and bone marrow cancers has involved doctors manually examining and classifying hundreds of cells under a microscope—an approach that is time-consuming but essential for identifying disease and determining cancer stage. More...

A newly developed artificial intelligence (AI) tool now offers a way to automate this process, according to findings published in Science Translational Medicine.

Developed by researchers at Memorial Sloan Kettering Cancer Center (MSK, New York, NY, USA) along with collaborators, the AI tool, named DeepHeme, was trained on nearly 50,000 labeled digital cell images. It was later evaluated using previously unseen cases, where it demonstrated performance that matched or surpassed that of expert pathologists. DeepHeme achieves expert-level diagnostic accuracy and reduces the time needed to analyze blood and bone marrow slides from over 30 minutes to just seconds. It is capable of evaluating both types of samples and has potential applications in advancing personalized medicine. Additionally, DeepHeme may support the discovery of new morphology-based biomarkers—visual cellular features that can aid in diagnosing disease, monitoring treatment responses, and forecasting disease progression. Identifying such biomarkers is key to furthering personalized treatment strategies.

At MSK, teams of researchers and technologists are actively exploring how AI can be leveraged to enhance patient care. These tools are designed not to replace clinical expertise but to augment it by increasing the speed and precision of data interpretation and enabling pattern recognition across large patient populations and disease variations. AI is already proving helpful in areas like mammogram interpretation, processing complex genomic data, and analyzing patient-reported treatment side effects. DeepHeme is part of a broader initiative to establish MSK as the first fully digital hematopathology service in the U.S., transitioning from physical glass slides and microscopes to digital formats. Beyond enabling AI use, digitized slides offer other advantages—they can be instantly reviewed from any location, eliminating the need for physical transport.

Digitized slide images can also be stored in a patient’s medical records. If follow-up tests are required, even years after the initial biopsy, clinicians can instantly access and compare past and present slides without retrieving physical specimens from archives. In addition to its clinical applications, digital pathology data supports research efforts such as MSK’s Cancer Data Science Initiative. This project collects millions of anonymized data points in near real time from patients receiving treatment at MSK. The resulting vast dataset provides researchers with valuable insights into which therapies are most effective for specific patient profiles and scenarios. Though the data is de-identified, the findings can help refine treatment decisions for both current and future patients. Following further validation, MSK intends to introduce DeepHeme into clinical use and may extend its availability by licensing it to other healthcare institutions.

“DeepHeme is just one example of MSK’s broader digital transformation,” said physician-scientist Ahmet Dogan, MD, PhD, Chief of MSK’s Hematopathology Service. “Now that we have high-resolution scans of every slide, we can use them to learn more about blood cancers in general.” 

Related Links:
MSK


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.